[HTML][HTML] A review of biological targets and therapeutic approaches in the management of triple-negative breast cancer
Background Triple-negative breast cancer (TNBC) is a heterogeneous, aggressive
phenotype of breast cancer with associated chemoresistance. The development of chemo-or …
phenotype of breast cancer with associated chemoresistance. The development of chemo-or …
Receptor tyrosine kinase inhibitors in cancer
N Ebrahimi, E Fardi, H Ghaderi, S Palizdar… - Cellular and Molecular …, 2023 - Springer
Targeted therapy is a new cancer treatment approach, involving drugs that particularly target
specific proteins in cancer cells, such as receptor tyrosine kinases (RTKs) which are …
specific proteins in cancer cells, such as receptor tyrosine kinases (RTKs) which are …
Mechanism insights of curcumin and its analogues in cancer: An update
P Joshi, K Verma, D Kumar Semwal… - Phytotherapy …, 2023 - Wiley Online Library
Cancer is the world's second leading cause of mortality and one of the major public health
problems. Cancer incidence and mortality rates remain high despite the great …
problems. Cancer incidence and mortality rates remain high despite the great …
Antioxidant Metabolism Pathways in Vitamins, Polyphenols, and Selenium: Parallels and Divergences
CMC Andrés, JM Pérez de la Lastra, CA Juan… - International Journal of …, 2024 - mdpi.com
Free radicals (FRs) are unstable molecules that cause reactive stress (RS), an imbalance
between reactive oxygen and nitrogen species in the body and its ability to neutralize them …
between reactive oxygen and nitrogen species in the body and its ability to neutralize them …
Vascular endothelial growth factor ligands and receptors in breast cancer
KK Brogowska, M Zajkowska, B Mroczko - Journal of Clinical Medicine, 2023 - mdpi.com
Breast cancer (BC) is the most common malignancy responsible for the largest number of
deaths in women worldwide. The risk of developing BC is predisposed by many factors such …
deaths in women worldwide. The risk of developing BC is predisposed by many factors such …
Applications of curcumin and its nanoforms in the treatment of cancer
D Mundekkad, WC Cho - Pharmaceutics, 2023 - mdpi.com
Due to the diverse medicinal and pharmacokinetic properties of turmeric, it is well-known in
the therapeutic, pharmaceutic, nutraceutical, cosmetic, and dietary industries. It gained …
the therapeutic, pharmaceutic, nutraceutical, cosmetic, and dietary industries. It gained …
Sigma-1 receptor signaling: in search of new therapeutic alternatives for cardiovascular and renal diseases
FJ Munguia-Galaviz, AG Miranda-Diaz… - International journal of …, 2023 - mdpi.com
Cardiovascular and renal diseases are among the leading causes of death worldwide, and
regardless of current efforts, there is a demanding need for therapeutic alternatives to …
regardless of current efforts, there is a demanding need for therapeutic alternatives to …
Targeting HER3 to overcome EGFR TKI resistance in NSCLC
Q Chen, G Jia, X Zhang, W Ma - Frontiers in Immunology, 2024 - frontiersin.org
Receptor tyrosine kinases (RTKs) play a crucial role in cellular signaling and oncogenic
progression. Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR TKIs) have …
progression. Epidermal growth factor receptor tyrosine kinase inhibitors (EGFR TKIs) have …
Exosome-mediated response to cancer therapy: Modulation of epigenetic machinery
MI Khan, RKME Alsayed, H Choudhry… - International Journal of …, 2022 - mdpi.com
Exosomes, the extracellular vesicles produced in the endosomal compartments, facilitate the
transportation of proteins as well as nucleic acids. Epigenetic modifications are now …
transportation of proteins as well as nucleic acids. Epigenetic modifications are now …
miRNA Expression Profiling in Human Breast Cancer Diagnostics and Therapy
I Dziechciowska, M Dąbrowska, A Mizielska… - Current Issues in …, 2023 - mdpi.com
Breast cancer is one of the most commonly diagnosed cancer types worldwide. Regarding
molecular characteristics and classification, it is a heterogeneous disease, which makes it …
molecular characteristics and classification, it is a heterogeneous disease, which makes it …